In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial
Adotevi, O., Godet, Y., Galaine, J., Lakkis, Z., Idirene, I., Certoux, J. M., Jary, M., Loyon, R., Laheurte, C., Kim, S., Dormoy, A., Pouthier, F., Barisien, C., Fein, F., Tiberghien, P., Pivot, X., Valmary-Degano, S., Ferrand, C., Morel, P., Delabrousse, E., Borg, C.
Published in Oncoimmunology (04.05.2018)
Published in Oncoimmunology (04.05.2018)
Get full text
Journal Article
Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts
Bôle-Richard, E, Gamonet, C, Certoux, J-M, Idirene, I, Larosa, F, Deconinck, E, Mosseley, A-M, Tiberghien, P, Borg, C, Ferrand, C, Deschamps, M
Published in Gene therapy (01.08.2016)
Published in Gene therapy (01.08.2016)
Get full text
Journal Article